High-Flow Nasal Oxygen Cannula Compared to Non-Invasive Ventilation in Adult Patients With AcuTE Respiratory Failure

NACompletedINTERVENTIONAL
Enrollment

1,801

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

November 30, 2023

Study Completion Date

February 28, 2024

Conditions
Respiratory InsufficiencyRespiratory Failure
Interventions
DEVICE

High Flow Nasal Catheter

"HFNC will deliver through AIRVO2. FiO2 from 21 to 100% and heated humidified gas flow up to 60 l / min with temperature of the circuit maintained at 37 degrees.~Oxygen flow will be offered through a humidified nasal catheter. Flow and FiO2 will be titrated according to the protocol to maximize patient´s comfort and SpO2."

DEVICE

Noninvasive ventilation

NIPPV will be performed using a facial mask (either oronasal or full face). NIPPV will deliver pressures and FiO2 tailored to specific ARF subgroups, according to the protocol. Adjustments of the inspiratory pressure (IPAP) and expiratory pressure (EPAP) and FiO2 according to protocol

Trial Locations (1)

05435000

Hospital do Coracao, São Paulo

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Ministry of Health, Brazil

OTHER_GOV

collaborator

Berry Consultants

OTHER

lead

Hospital do Coracao

OTHER